From the September 2024 issue of UCLA Health's Healthy Years (HY)
First Drug for Resistant Hypertension Approved
You are trying to access subscriber-only content.
If you are a subscriber, .
If you are not a subscriber, or are only subscribed to the print edition, click here to subscribe now. Digital subscribers have unlimited access to our magazine articles and more!
In March 2024, the FDA approved once-daily aprocitentan (brand name TRYVIO) for treating high blood pressure in adults who don’t respond well to other medications. About 10% of people with hypertension pressure cannot reach recommended levels even with existing treatments. Aprocitentan works by blocking endothelin, a substance that narrows blood vessels and raises blood pressure. […]
© FatCamera | GettyImages